[Clinical significance of YH-206 assay analysis as a tumor marker].
作者信息
Yachi A, Hinoda Y, Imai K, Endo T
机构信息
Department of Internal Medicine (Section I), Sapporo Medical College.
出版信息
Nihon Rinsho. 1990 Feb;48 Suppl:1068-70.
PMID:2192107
Abstract
摘要
相似文献
1
[Clinical significance of YH-206 assay analysis as a tumor marker].[YH - 206检测分析作为肿瘤标志物的临床意义]
Nihon Rinsho. 1990 Feb;48 Suppl:1068-70.
2
[Clinical significance of ST 272 Ag detected by the monoclonal antibody, NCC-ST-272].[单克隆抗体NCC-ST-272检测ST 272抗原的临床意义]
Nihon Rinsho. 1990 Feb;48 Suppl:1028-30.
3
[Clinical significance of DU-PAN-2 analysis as a tumor marker].[DU-PAN-2分析作为肿瘤标志物的临床意义]
Nihon Rinsho. 1990 Feb;48 Suppl:1003-7.
4
[Clinical significance of pancreatic oncofetal antigen, pancreatic cancer associated antigen assay as tumor markers].[胰腺癌胎儿抗原、胰腺癌相关抗原作为肿瘤标志物检测的临床意义]
Nihon Rinsho. 1990 Feb;48 Suppl:917-9.
5
[Clinical significance of NCC-ST-439 antigen assay detected by the monoclonal antibody as a tumor marker].[单克隆抗体检测的NCC-ST-439抗原测定作为肿瘤标志物的临床意义]
Nihon Rinsho. 1990 Feb;48 Suppl:1031-4.
6
[Clinical significance of TAC-41 assay as a tumor marker].[TAC - 41检测作为肿瘤标志物的临床意义]
Nihon Rinsho. 1990 Feb;48 Suppl:1060-3.
7
[CA72-4 (TAG-72)].[癌抗原72-4（TAG-72）]
Nihon Rinsho. 2005 Aug;63 Suppl 8:672-4.
8
[Clinical significance of TAG-72 assay as a tumor marker].[TAG-72检测作为肿瘤标志物的临床意义]
Nihon Rinsho. 1990 Feb;48 Suppl:1064-7.
9
[Evaluation of KMO1 for the gastrointestinal disease].[KMO1用于胃肠道疾病的评估]
Nihon Rinsho. 1990 Feb;48 Suppl:1017-21.
10
[Clinical significance of CA 195 assay as a tumor marker].[CA 195检测作为肿瘤标志物的临床意义]
Nihon Rinsho. 1990 Feb;48 Suppl:982-4.
Zotero 插件